What Is MET Fair Value?
MetLife (MET) fair value estimate using multiple valuation models, updated daily.
As of July 16, 2026, MetLife (MET) has a composite fair value estimate of $122.87 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $92.20, suggesting the stock is undervalued by 33.3%.
Data as of July 16, 2026 (today)
Composite Fair Value
Undervalued4 of 4 models$122.87
vs. current price of $92.20(+33.3%)
How Is MET Fair Value Calculated?
Four independent models estimate what MET is worth. Each uses different inputs and assumptions. The composite blends them by weight.
MET Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$138.20
+49.9%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$85.50
-7.3%Fair Value
Inputs used
MET Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$96.99
+5.2%Fair Value
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$115.55
+25.3%Undervalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $92.20 is 49.9% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $2.66B | $2.49B |
| Year 2 | $2.97B | $2.61B |
| Year 3 | $3.32B | $2.74B |
| Year 4 | $3.70B | $2.87B |
| Year 5 | $4.14B | $3.01B |
| Year 6 | $4.62B | $3.15B |
| Year 7 | $5.16B | $3.30B |
| Year 8 | $5.76B | $3.46B |
| Year 9 | $6.44B | $3.63B |
| Year 10 | $7.19B | $3.80B |
| Terminal Value | $180.49B | $95.41B |
What Are MET's Key Financial Metrics?
Earnings & Growth
Current Price
$92.20
EPS (TTM)
$5.15
Forward P/E
8.4
Profit Margin
4.7%
Cash & Balance Sheet
Free Cash Flow
-17.4B
EBITDA
5.9B
Book Value
$42.30
Total Debt
49.5B
What Do Analysts Say About MET?
Low
$75.00
Average
$96.00
High
$105.00
Upside
+4.1%
MET Fair Value FAQ
What is the fair value of MET?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), MET's estimated fair value is $122.87. The stock is currently trading at $92.20, which makes it undervalued by our analysis.
How is MET's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is MET overvalued or undervalued?
Based on our analysis, MET is undervalued. The current price of $92.20 is 33.3% below our estimated fair value of $122.87.
What do Wall Street analysts say about MET?
16 analysts cover MetLife with a consensus rating of "Buy." The average price target is $96.00, ranging from $75.00 to $105.00. This implies 4.1% upside from the current price.